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Painful crises are the major sickle-cell disease (SCD) clinical manifestation probably 
due to significant increase in dense red blood cells (RBC) and reduction of their 
ability to pass through capillaries. Using proteomic strategies (see figure below), we 
aimed to discover novel SCD prognosis biomarkers  as early predictors of the 
transition from steady-state to vaso-occlusive crises thus, allowing a prompt and 
specific  therapeutic intervention.  
 
Plasma and RBC from peripheral blood of 
SCD (SS) patients in steady-state or 
undergoing a vaso-occlusive episode 
(n=12). Plasma was depleted of the 14 
most abundant proteins using the MARS-14 
and RBC were membrane/soluble 
fractionated, the later was haemoglobin 
depleted using HemoVoidTM 
Samples were labeled with Lumiproble 
3DyeTM 2D DIGE kit and separated by 2DE 
(pH 4-7 and 3-10, respectively). The 2D-
images were acquired in a Thyphoon 
Imager and analysed by Progenesis 
SameSpots. Differentially expressed spots 
were identified by MALDI-TOF/TOF MS. 
Functional characterization was achieved 
by different bioinformatic resources (IPA, 
GO, PIKE). 
In RBC-soluble fraction 2DIGE maps, 
more than 900 spots per gel were 
resolved and a total of 226 spots 
differentially expressed spots were 
recognized, corresponding a 134 
proteins by MS analysis (see figures 
1- 5). 
Molecular functions and associated pathways revealed 
enrichment in proteins involved in haematological  
disease, cytoskeleton rearrangements, signal 
transduction or response to reactive oxygen species, 
altered   mechanisms with implications in SCD vaso-
occlusive episodes. Further complete characterization 
and validation of differently expressed proteins in both 
RBC and plasma may constitute a specific biosignature of 
steady-state to crisis transition in SCD.  
Conclusion 
Authors would like to thank all patients, their relatives and healthy individuals who voluntarily participated in this study.  Work 
partially funded by FCT grant PIC/IC/83084/2007 and CIGMH , and FEDER/SaúdeXXI program.  
Acknowledgements: 
References: 
Pasini EM et al. J Proteomics 2010;73:403-20.   
Roux-Dalvai et al. Mol Cel Proteomics 2008;7:2254-69. 
Heywood WE et al. Proteome Sci. 2011;9:56.  
Charro N et al. J Proteomics. 2011;74:110-26 . 
 
